| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 131 | / | 2014 | | | |
| | Date of issue: | 2014-12-12 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 131 buy back 12122014 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | SOPHARMA AD hereby informs that from 4 December 2014 up to and including 10 December 2014 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 796 BGN on the Bulgarian Stock Exchange, the average price per share was 3.98 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 113 043, representing 3.87% of the share capital of the Company.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | Current report 131 buy back 12122014 | |
